Navigation Links
Easily Lift, Transfer and Reposition Patients with Ground-Breaking Liftaem(TM) System from Smart Medical Technology, Inc.
Date:11/12/2007

DARIEN, Ill., Nov. 12 /PRNewswire/ -- The Liftaem(TM) safe-patient- handling system enables healthcare professionals to easily transfer a patient from a bed to a stretcher or other surface on a single-patient-use inflatable mat -- even when the patient weighs up to 1,000 lbs. It's the only product of its kind featuring single-patient-use mats to prevent cross-contamination -- a priority in health care.

"Our vision is to develop culture-changing innovations to better manage and monitor healthcare environments," states Smart Medical Technology Chairman and CEO James Patrick. "We believe therapy and safety should always share the same platform."

The inflatable mats are placed on the patients' beds when they are admitted and remain with them for the duration of their stay. Carts used for inflation are placed throughout the hospital in areas with high numbers of patient transfers.

Smart Medical Technology developed the Liftaem(TM) to address the serious problems associated with manually lifting, transferring and repositioning patients, including:

-- Nurses lose a combined average of 750,000 work days each year as a

result of back injury, according to the U.S. Bureau of Labor

Statistics.

-- Patients may suffer pain, skin tears, abrasions, dislocations, tube

dislodgement or even be dropped.

Liftaem(TM) has applications in areas such as bariatrics, maternity wards, operating rooms, intensive care and long-term care facilities.

For additional information on the Liftaem(TM) safe-patient-handling system, contact James Patrick at 630.964.1689 or visit http://www.smartmedtechnology.com.

Smart Medical Technology, Inc. is a creative design and manufacturing company that develops solutions for the healthcare industry to improve patient care and reduce expenses -- http://www.smartmedtechnology.com.

Contact:

James Patrick

jepatrick@smartmedtechnology.com

phone: 630.964.1689

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Smart Medical Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
4. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
5. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
6. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
11. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):